The finding that separase is overexpressed in several cancers, including CML renders this protease a key subject of investigation to unravel the molecular mechanisms involved in the development of centrosome amplification in IM-treated CML [18], [30], [36], [37]. The gene discussed is ESPL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.